Profound Medical Corp. Operating Income 2011-2026 | PROF

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Profound Medical Corp.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-30.3 M	-18.9 M	-14.9 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-14.9 M	-30.3 M	-21.4 M

Operating Income of other stocks in the Medical devices industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Abbott Laboratories ABT	8.05 B	$ 102.87	0.48 %	$ 179 B	USA
Align Technology ALGN	608 M	$ 170.6	-1.23 %	$ 12.8 B	USA
Apollo Endosurgery APEN	-31.4 M	-	-	$ 475 M	USA
Acutus Medical AFIB	-11.7 M	-	-26.83 %	$ 2.62 M	USA
Avinger AVGR	-16.6 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-64.9 M	-	-	$ 3.31 B	USA
Alphatec Holdings ATEC	-82.1 M	$ 10.83	-3.82 %	$ 1.63 B	USA
Aziyo Biologics AZYO	-26.9 M	-	1.37 %	$ 20.5 M	USA
Allied Healthcare Products AHPI	-1.27 M	-	3.58 %	$ 2.21 M	USA
AxoGen AXGN	-7.85 M	$ 34.44	2.56 %	$ 1.59 B	USA
BioSig Technologies BSGM	-71.1 M	-	37.08 %	$ 85.7 M	USA
ClearPoint Neuro CLPT	-24.2 M	$ 9.37	2.52 %	$ 265 M	USA
Accuray Incorporated ARAY	7.84 M	$ 0.42	6.82 %	$ 43.2 M	USA
Cardiovascular Systems CSII	-35.8 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-156 M	-	-10.19 %	$ 1.99 M	USA
Cytosorbents Corporation CTSO	-14.7 M	$ 0.58	6.52 %	$ 36.1 M	USA
Delcath Systems DCTH	660 K	$ 9.63	0.94 %	$ 345 M	USA
Dynatronics Corporation DYNT	-2.45 M	-	14.99 %	$ 929 K	USA
Eargo EAR	-112 M	-	-	$ 10.2 M	USA
Electromed ELMD	9.66 M	$ 23.29	-1.52 %	$ 197 M	USA
Bruker Corporation BRKR	253 M	$ 36.76	1.88 %	$ 5.48 K	USA
Boston Scientific Corporation BSX	3.61 B	$ 62.82	1.32 %	$ 93 B	USA
Conformis CFMS	-46.3 M	-	-	$ 16.4 M	USA
Edwards Lifesciences Corporation EW	1.26 B	$ 81.05	-0.26 %	$ 47.4 B	USA
CONMED Corporation CNMD	103 M	$ 34.79	-2.08 %	$ 1.08 B	USA
Neovasc NVCN	-31.1 M	-	-	$ 111 M	Canada
Second Sight Medical Products EYES	-27.6 M	-	-0.97 %	$ 54.4 M	USA
Aethlon Medical AEMD	-9.34 M	$ 2.12	-1.4 %	$ 3.31 M	USA
BIOLASE BIOL	-17.9 M	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	90.9 M	$ 12.03	1.43 %	$ 1.63 B	USA
Helius Medical Technologies HSDT	-12.4 M	$ 1.86	9.41 %	$ 1.13 M	USA
Integra LifeSciences Holdings Corporation IART	28.4 M	$ 9.53	-0.42 %	$ 734 M	USA
Inogen INGN	-30.2 M	$ 6.21	-0.96 %	$ 165 M	USA
Inspire Medical Systems INSP	51 M	$ 54.99	2.52 %	$ 1.61 B	USA
OrthoPediatrics Corp. KIDS	-39.2 M	$ 16.06	-1.41 %	$ 377 M	USA
IRIDEX Corporation IRIX	-2.57 M	$ 0.98	3.17 %	$ 16.6 M	USA
Invacare Corporation IVC	-80.5 M	-	-	$ 24.7 M	USA
Integer Holdings Corporation ITGR	221 M	$ 86.85	0.47 %	$ 3.02 B	USA
LivaNova PLC LIVN	199 M	$ 63.79	-1.3 %	$ 3.48 B	Britain
LENSAR LNSR	-24.6 M	$ 6.06	1.51 %	$ 72.5 M	USA